A Review of Digital Interventions to Decrease Cannabis Use Among Patients With Comorbid Psychiatric Disorders.

IF 1.5 4区医学 Q3 PSYCHIATRY

Journal of Dual Diagnosis Pub Date : 2022-10-01 Epub Date: 2022-09-30 DOI:10.1080/15504263.2022.2126058

Laura Whiteley, Elizabeth M Olsen, Kayla K Haubrick, Chaerim Kang, Ian Vaughan, Larry K Brown

{"title":"A Review of Digital Interventions to Decrease Cannabis Use Among Patients With Comorbid Psychiatric Disorders.","authors":"Laura Whiteley, Elizabeth M Olsen, Kayla K Haubrick, Chaerim Kang, Ian Vaughan, Larry K Brown","doi":"10.1080/15504263.2022.2126058","DOIUrl":null,"url":null,"abstract":"Objective: Cannabis use disorder (CUD) is associated with an elevated risk for psychiatric disorders and symptoms, contributing to poor health outcomes and increased medical costs. Unfortunately, interventions that simultaneously address cannabis use and co-occurring psychiatric disorders are limited in availability. Targeted digital interventions to reduce cannabis use could be beneficial for patients with psychiatric disorders. Digital interventions could be easily disseminated and used in numerous clinical locations, including outpatient, inpatient, residential, and community psychiatric treatment settings.Methods: Literature on digital cannabis reduction interventions for persons with psychiatric disorders was examined between April 2021 and June 2021. Articles were obtained from PubMed and PsycINFO databases. English language randomized controlled trials (RCT), feasibility and acceptability studies, pilot studies, and published protocols were included.Results: There is significant evidence that digital interventions can effectively reduce cannabis use in general, non-clinical populations. However, there is less literature examining interventions for persons living with co-occurring psychiatric illness-most of which is tailored to patients living with chronic psychosis.Conclusions: There is great need for accessible and tailored digital interventions for co-occurring CUD and psychiatric disorders.","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311985/pdf/nihms-1891697.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dual Diagnosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15504263.2022.2126058","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 1

Abstract

Objective: Cannabis use disorder (CUD) is associated with an elevated risk for psychiatric disorders and symptoms, contributing to poor health outcomes and increased medical costs. Unfortunately, interventions that simultaneously address cannabis use and co-occurring psychiatric disorders are limited in availability. Targeted digital interventions to reduce cannabis use could be beneficial for patients with psychiatric disorders. Digital interventions could be easily disseminated and used in numerous clinical locations, including outpatient, inpatient, residential, and community psychiatric treatment settings.

Methods: Literature on digital cannabis reduction interventions for persons with psychiatric disorders was examined between April 2021 and June 2021. Articles were obtained from PubMed and PsycINFO databases. English language randomized controlled trials (RCT), feasibility and acceptability studies, pilot studies, and published protocols were included.

Results: There is significant evidence that digital interventions can effectively reduce cannabis use in general, non-clinical populations. However, there is less literature examining interventions for persons living with co-occurring psychiatric illness-most of which is tailored to patients living with chronic psychosis.

Conclusions: There is great need for accessible and tailored digital interventions for co-occurring CUD and psychiatric disorders.

查看原文本刊更多论文

减少合并精神病患者大麻使用的数字干预综述。

目的：大麻使用障碍（CUD）与精神障碍和症状的风险增加有关，导致健康状况不佳和医疗费用增加。不幸的是，同时解决大麻使用和同时发生的精神障碍的干预措施的可用性有限。减少大麻使用的有针对性的数字干预措施可能对精神障碍患者有益。数字干预可以很容易地在许多临床场所传播和使用，包括门诊、住院、住院和社区精神病治疗环境。方法：在2021年4月至2021年6月期间，研究了针对精神障碍患者的数字大麻减少干预措施的文献。文章来自PubMed和PsycINFO数据库。包括英语随机对照试验（RCT）、可行性和可接受性研究、试点研究和已发表的方案。结果：有重要证据表明，数字干预可以有效减少普通非临床人群的大麻使用。然而，研究对合并精神病患者的干预措施的文献较少，其中大多数是为慢性精神病患者量身定制的。结论：对于同时发生的CUD和精神疾病，非常需要可获得和量身定制的数字干预。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Dual Diagnosis Multiple-

CiteScore

4.90

自引率

13.60%

发文量

期刊介绍： Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment? The Journal addresses each of these perplexing challenges.